The review panel shall examine the following areas relating to fungal contamination in indoor environments:
- (a) Medical and public health.
- (b) Evaluation and monitoring.
- (c) Remediation and prevention.
- (d) Educational materials.
- (e) Hazard communication.
- (f) Any other area identified by the review panel.